CANTEL MEDICAL CORP's ticker is CMD and the CUSIP is 138098108. A total of 215 filers reported holding CANTEL MEDICAL CORP in Q1 2020. The put-call ratio across all filers is 1.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $541,000 | +25.5% | 6,776 | +24.0% | 0.00% | 0.0% |
| Q4 2020 | $431,000 | +95.9% | 5,463 | +9.3% | 0.00% | 0.0% |
| Q3 2020 | $220,000 | -68.0% | 5,000 | -67.8% | 0.00% | -72.7% |
| Q2 2020 | $687,000 | -13.6% | 15,532 | -29.9% | 0.01% | -45.0% |
| Q1 2020 | $795,000 | -44.5% | 22,144 | +15.6% | 0.02% | +53.8% |
| Q3 2019 | $1,432,000 | +71.7% | 19,150 | +85.2% | 0.01% | +62.5% |
| Q2 2019 | $834,000 | +22.5% | 10,341 | +1.5% | 0.01% | +14.3% |
| Q1 2019 | $681,000 | -70.9% | 10,186 | -67.6% | 0.01% | -74.1% |
| Q4 2018 | $2,344,000 | -24.0% | 31,480 | -6.0% | 0.03% | -27.0% |
| Q3 2018 | $3,084,000 | -63.2% | 33,502 | -60.7% | 0.04% | -66.7% |
| Q2 2018 | $8,387,000 | +1363.7% | 85,269 | +1558.3% | 0.11% | +1133.3% |
| Q1 2018 | $573,000 | +69.0% | 5,142 | +55.9% | 0.01% | +50.0% |
| Q4 2017 | $339,000 | -70.5% | 3,298 | -73.0% | 0.01% | -72.7% |
| Q3 2017 | $1,149,000 | +259.1% | 12,199 | +162.1% | 0.02% | +10.0% |
| Q2 2016 | $320,000 | – | 4,654 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DIKER MANAGEMENT LLC | 1,084,317 | $85,509,000 | 43.23% |
| Leonard Green & Partners, L.P. | 2,100,000 | $165,606,000 | 2.29% |
| Champlain Investment Partners, LLC | 3,952,620 | $311,704,000 | 1.79% |
| Brown Capital Management | 2,454,770 | $193,583,000 | 1.34% |
| Aurora Investment Counsel | 19,502 | $1,538,000 | 1.24% |
| Conestoga Capital Advisors, LLC | 797,481 | $62,889,000 | 1.00% |
| EMERALD ADVISERS, LLC | 292,554 | $23,071,000 | 0.77% |
| FRED ALGER MANAGEMENT, LLC | 3,470,340 | $273,671,000 | 0.71% |
| GENEVA CAPITAL MANAGEMENT LLC | 510,171 | $40,232,000 | 0.68% |
| WASHINGTON CAPITAL MANAGEMENT, INC | 7,650 | $603,000 | 0.58% |